Clinical controversies: Proton therapy for pediatric tumors

Seminars in Radiation Oncology

Volumn 23, Issue 2, 2013, Pages 97-108

  Merchant, Thomas E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RISK; CEREBROVASCULAR ACCIDENT; CHILDHOOD CANCER; COCHLEA; COGNITION; CRANIOPHARYNGIOMA; DOSIMETRY; EPENDYMOMA; EWING SARCOMA; FUNCTIONAL STATUS; HUMAN; MEDULLOBLASTOMA; MENTAL DEFICIENCY; METASTASIS; NECROSIS; NEUROBLASTOMA; ONCOLOGY; OTOTOXICITY; PHOTON; PRIORITY JOURNAL; PROTON THERAPY; QUALITY OF LIFE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RETROPERITONEAL NEUROBLASTOMA; RISK REDUCTION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; ORGANS AT RISK; PEDIATRICS; PROTON THERAPY; QUALITY OF LIFE; RADIATION ONCOLOGY; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 84875279261     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2012.11.008     Document Type: Article

References (59)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
2. Laffond C., Dellatolas G., Alapetite C., et al. Quality-of-life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy. Brain Inj 2012, 26:270-281.
3. Merchant T.E., Kiehna E.N., Kun L.E., et al. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J Neurosurg 2006, 104:94-102.
4. Rajan B., Ashley S., Thomas D.G., et al. Craniopharyngioma: Improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys 1997, 37:517-521.
5. Winkfield K.M., Linsenmeier C., Yock T.I., et al. Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy. Int J Radiat Oncol Biol Phys 2009, 73:716-721.
6. Baumert B.G., Norton I.A., Lomax A.J., et al. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. Int J Radiat Oncol Biol Phys 2004, 60:1314-1324.
7. Boehling N.S., Grosshans D.R., Bluett J.B., et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys 2012, 82:643-652.
8. Beltran C., Roca M., Merchant T.E. On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiat Oncol Biol Phys 2012, 82:e281-e287.
9. Merchant T.E., Hua C.H., Shukla H., et al. Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 2008, 51:110-117.
10. Merchant T.E., Conklin H., Onar A., et al. Longitudinal models of cognitive function in children with craniopharyngioma demonstrate the effect of radiation dose. Pediatr Blood Cancer 2011, 804.
11. Luu Q.T., Loredo L.N., Archambeau J.O., et al. Fractionated proton radiation treatment for pediatric craniopharyngioma: Preliminary report. Cancer J 2006, 12:155-159.
12. Fitzek M.M., Linggood R.M., Adams J., et al. Combined proton and photon irradiation for craniopharyngioma: Long-term results of the early cohort of patients treated at Harvard Cyclotron Laboratory and Massachusetts General Hospital. Int J Radiat Oncol Biol Phys 2006, 64:1348-1354.
13. Gerelchuluun A., Hong Z., Sun L., et al. Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines. Int J Radiat Biol 2011, 87:57-70.
14. Jones B., Wilson P., Nagano A., et al. Dilemmas concerning dose distribution and the influence of relative biological effect in proton beam therapy of medulloblastoma. Br J Radiol 2012, 85:e912-e918.
15. Miralbell R., Lomax A., Russo M. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuro-ectodermal tumors: Spinal theca irradiation. Int J Radiat Oncol Biol Phys 1997, 38:805-811.
16. St Clair W.H., Adams J.A., Bues M., et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys 2004, 58:727-734.
17. Lee C.T., Bilton S.D., Famiglietti R.M., et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques?. Int J Radiat Oncol Biol Phys 2005, 63:362-372.
18. Blomstrand M., Brodin N.P., Munck Af Rosenschöld P., et al. Estimated clinical benefit of protecting neurogenesis in the developing brain during radiation therapy for pediatric medulloblastoma. Neuro Oncol 2012, 14:882-889.
19. Merchant T.E., Kiehna E.N., Li C., et al. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma. Int J Radiat Oncol Biol Phys 2006, 65:210-221.
20. Miralbell R., Lomax A., Bortfeld T., et al. Potential role of proton therapy in the treatment of pediatric medulloblastoma/primitive neuroectodermal tumors: Reduction of the supratentorial target volume. Int J Radiat Oncol Biol Phys 1997, 38:477-484.
21. Kuhlthau K.A., Pulsifer M.B., Yeap B.Y., et al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 2012, 30:2079-2086.
22. Brodin N.P., Munck Af Rosenschöld P., Aznar M.C., et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma. Acta Oncol 2011, 50:806-816.
23. Taddei P.J., Mahajan A., Mirkovic D., et al. Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation. Phys Med Biol 2010, 55:7067-7080.
24. Timmermann B., Lomax A.J., Nobile L., et al. Novel technique of craniospinal axis proton therapy with the spot-scanning system: Avoidance of patching multiple fields and optimized ventral dose distribution. Strahlenther Onkol 2007, 183:685-688.
25. Brodin N.P., Vogelius I.R., Maraldo M.V., et al. Life years lost-comparing potentially fatal late complications after radiotherapy for pediatric medulloblastoma on a common scale. Cancer 2012, 118:5432-5440.
26. Miralbell R., Lomax A., Cella L., et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002, 54:824-829.
27. Yuh G.E., Loredo L.N., Yonemoto L.T., et al. Reducing toxicity from craniospinal irradiation: Using proton beams to treat medulloblastoma in young children. Cancer J 2004, 10:386-390.
28. Lew S.M., Morgan J.N., Psaty E., et al. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg 2006, 104:103-107.
29. Cochran D.M., Yock T.I., Adams J.A., et al. Radiation dose to the lens during craniospinal irradiation-an improvement in proton radiotherapy technique. Int J Radiat Oncol Biol Phys 2008, 70:1336-1342.
30. Hartley K.A., Li C., Laningham F.H., et al. Vertebral body growth after craniospinal irradiation. Int J Radiat Oncol Biol Phys 2008, 70:1343-1349.
31. Gensheimer M.F., Yock T.I., Liebsch N.J., et al. In vivo proton beam range verification using spine MRI changes. Int J Radiat Oncol Biol Phys 2010, 78:268-275.
32. Lundkvist J., Ekman M., Ericsson S.R., et al. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer 2005, 103:793-801.
33. Evans A.E., Anderson J.R., Lefkowitz-Boudreaux I.B., et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: Cranio-spinal irradiation with or without adjuvant CCNU, vincristine, and prednisone: A childrens Cancer Group study. Med Pediatr Oncol 1996, 27:8-14.
34. Merchant T.E., Li C., Xiong X., et al. Conformal radiotherapy after surgery for paediatric ependymoma: A prospective study. Lancet Oncol 2009, 10:258-266.
35. Conklin H.M., Li C., Xiong X., et al. Predicting change in academic abilities after conformal radiation therapy for localized ependymoma. J Clin Oncol 2008, 26:3965-3970.
36. Di Pinto M., Conklin H.M., Li C., et al. Investigating verbal and visual auditory learning after conformal radiation therapy for childhood ependymoma. Int J Radiat Oncol Biol Phys 2010, 77:1002-1008.
37. Netson K.L., Conklin H.M., Wu S., et al. A 5-year Investigation of children's adaptive functioning following conformal radiation therapy for localized ependymoma. Int J Radiat Oncol Biol Phys 2012, 84:217-223. e1.
38. MacDonald S.M., Safai S., Trofimov A., et al. Proton radiotherapy for childhood ependymoma: Initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys 2008, 71:979-986.
39. Habrand J.L., Bolle S., Datchary J., et al. [Proton beam therapy in pediatric radiotherapy]. Cancer Radiother 2009, 13:550-555.
40. Merchant T.E., Palmer S.L., Lukose R., et al. Critical combinations of radiation dose and volume predict IQ and academic achievement after craniospinal irradiation in children. Int J Radiat Oncol Biol Phys 2011, 78:S17-S18.
41. Merchant T.E., Gould C.J., Xiong X., et al. Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Oncol Biol Phys 2004, 58:1194-1207.
42. Hua C., Bass J.K., Khan R., et al. Hearing loss after radiotherapy for pediatric brain tumors: Effect of cochlear dose. Int J Radiat Oncol Biol Phys 2008, 72:892-899.
43. Merchant T.E., Rose S.R., Bosley C., et al. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol 2011, 29:4776-4780.
44. Murphy E.S., Merchant T.E., Wu S., et al. Necrosis after craniospinal irradiation: Results from a prospective series of children with central nervous system tumors. Int J Radiat Oncol Biol Phys 2012, 83:e655-e660.
45. Bishop M.W., Hummel T.R., Leach J., et al. Radiation injury in pediatric patients with CNS tumors treated with proton beam radiation therapy. Neuro Oncol 2012, 14:i148-i156.
46. Sabin ND, Merchant TE, Harreld JH, et al: Imaging changes in very young children with brain tumors treated with proton therapy and chemotherapy. AJNR Am J Neuroradiol (in press).
47. Merchant T.E. A phase II trial of limited surgery and proton therapy for craniopharyngioma and observation for craniopharyngioma after radical resection, 2012 Accessed November 27, 2012. http://clinicaltrials.gov/ct2/results?term=RT2CR.
48. Fogliata A., Yartsev S., Nicolini G., et al. On the performances of intensity modulated protons, rapid arc and helical tomotherapy for selected paediatric cases. Radiat Oncol 2009, 4:2.
49. Rombi B., DeLaney T.F., MacDonald S.M., et al. Proton radiotherapy for pediatric Ewing's sarcoma: Initial clinical outcomes. Int J Radiat Oncol Biol Phys 2012, 82:1142-1148.
50. DeLaney T.F., Liebsch N.J., Pedlow F.X., et al. Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas. Int J Radiat Oncol Biol Phys 2009, 74:732-739.
51. Isacsson U., Hagberg H., Johansson K.A., et al. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997, 45:63-70.
52. Hattangadi J., Esty B., winey B., et al. Radiation recall myositis in pediatric Ewing sarcoma. Pediatr Blood Cancer 2011, 59:570-572.
53. Hug E.B., Nevinny-Stickel M., Fuss M., et al. Conformal proton radiation treatment for retroperitoneal neuroblastoma: Introduction of a novel technique. Med Pediatr Oncol 2001, 37:36-41.
54. Hillbrand M., Georg D., Gadner H., et al. Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy. Radiother Oncol 2008, 89:141-149.
55. Hattangadi J.A., Rombi B., Yock T.I., et al. Proton radiotherapy for high-risk pediatric neuroblastoma: Early outcomes and dose comparison. Int J Radiat Oncol Biol Phys 2012, 83:1015-1022.
56. Barbaro P.M., Johnston K., Dalla-Pozza L., et al. Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy. Ann Oncol 2011, 22:2569-2574.
57. Andolino D.L., Hoene T., Xiao L., et al. Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients. Int J Radiat Oncol Biol Phys 2011, 81:e667-e671.
58. Hoppe B.S., Flampouri S., Su Z., et al. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 2012, 84:449-455.
59. Hodgson D.C., Dong L. Proton therapy for Hodgkin lymphoma: Does a case report make the case?. Leuk Lymphoma 2010, 51:1397-1398.